2002: June: Alzheimer’s Research Papers
Wang L, Andersson S, Warner M, Gustafsson JA. Estrogen actions in the brain. Sci STKE. 2002 Jun 25;2002(138):PE29.
Fishman RA. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type. Neurology. 2002 Jun 25;58(12):1866.
Russo C, Dolcini V, Salis S, Venezia V, Zambrano N, Russo T, Schettini G. Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain. J Biol Chem. 2002 Jun 25;
Bazin HG, Marques MA, Owens AP, Linhardt RJ, Crutcher KA. Inhibition of apolipoprotein E-related neurotoxicity by glycosaminoglycans and their oligosaccharides. Biochemistry. 2002 Jun 25;41(25):8203-11.
Wurth C, Guimard NK, Hecht MH. Mutations that Reduce Aggregation of the Alzheimer's Abeta42 Peptide: an Unbiased Search for the Sequence Determinants of Abeta Amyloidogenesis. J Mol Biol. 2002 Jun 21;319(5):1279-90.
Jeon JH, Cho SY, Kim CW, Shin DM, Kweon JC, Choi KH, Park SC, Kim IG. GTP is required to stabilize and display transamidation activity of transglutaminase 2. Biochem Biophys Res Commun. 2002 Jun 21;294(4):818-22.
Schulte T, Schöls L, Müller T, Woitalla D, Berger K, Krüger R. Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease. Neurosci Lett. 2002 Jun 21;326(1):70-2.
Emilsson L, Saetre P, Balciuniene J, Castensson A, Cairns N, Jazin EE. Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients. Neurosci Lett. 2002 Jun 21;326(1):56-60.
Sennvik K, Nilsberth C, Stenh C, Lannfelt L, Benedikz E. The Arctic Alzheimer mutation enhances sensitivity to toxic stress in human neuroblastoma cells. Neurosci Lett. 2002 Jun 21;326(1):51-5.
Tamo W, Imaizumi T, Tanji K, Yoshida H, Mori F, Yoshimoto M, Takahashi H, Fukuda I, Wakabayashi K, Satoh K. Expression of alpha-synuclein, the precursor of non-amyloid beta component of Alzheimer's disease amyloid, in human cerebral blood vessels. Neurosci Lett. 2002 Jun 21;326(1):5-8.
Motonaga K, Itoh M, Becker LE, Goto Y, Takashima S. Elevated expression of beta-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome. Neurosci Lett. 2002 Jun 21;326(1):64-6.
Combarros O, Infante J, Llorca J, Peña N, Fernández-Viadero C, Berciano J. The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis. Neurosci Lett. 2002 Jun 21;326(1):33-6. ,
Prat MI, Adamo AM, González SA, Affranchino JL, Ikeda M, Matsubara E, Shoji M, Smith MA, Castaño EM, Morelli L. Presenilin 1 overexpressions in Chinese hamster ovary (CHO) cells decreases the phosphorylation of retinoblastoma protein: relevance for neurodegeneration. Neurosci Lett. 2002 Jun 21;326(1):9-12.
Müller B. Cytokine imbalance in non-immunological chronic disease. Cytokine. 2002 Jun 21;18(6):334.
Straub JE, Guevara J, Huo S, Lee JP. Long Time Dynamic Simulations: Exploring the Folding Pathways of an Alzheimer's Amyloid Abeta-Peptide. Acc Chem Res. 2002 Jun 18;35(6):473-481.
Fern ndez Lastra A, Molares Rodr guez M, Penzol D az J. [Associated EMG responses in Alzheimer s disease and in healthy subjects] Rev Neurol. 2002 Jun 16;34(12):1109-12.
Drake J, Kanski J, Varadarajan S, Tsoras M, Butterfield DA. Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J Neurosci Res. 2002 Jun 15;68(6):776-84.
Sela M, Arnon R, Schechter B. Therapeutic vaccines: realities of today and hopes for the future. Drug Discov Today. 2002 Jun 15;7(12):664-673.
Giasson BI, Ischiropoulos H, Lee VM, Trojanowski JQ. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases(1,2). Free Radic Biol Med. 2002 Jun 15;32(12):1264-75.
Cummings JL, Frank JC, Cherry D, Kohatsu ND, Kemp B, Hewett L, Mittman B. Guidelines for managing Alzheimer's disease: Part II. Treatment. Am Fam Physician. 2002 Jun 15;65(12):2525-34.
Caselli RJ, Reiman EM, Hentz JG, Osborne D, Alexander GE, Boeve BF. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes. Sleep. 2002 Jun 15;25(4):447-53.
Raber J, Bongers G, LeFevour A, Buttini M, Mucke L. Androgens protect against apolipoprotein E4-induced cognitive deficits. J Neurosci. 2002 Jun 15;22(12):5204-9.
Green KN, Boyle JP, Peers C. Hypoxia potentiates exocytosis and Ca(2+) channels in PC12 cells via increased amyloid beta peptide formation and reactive oxygen species generation. J Physiol. 2002 Jun 15;541(Pt 3):1013-1023.
Doré S. Decreased activity of the antioxidant heme oxygenase enzyme: implications in ischemia and in Alzheimer's disease(1,2). Free Radic Biol Med. 2002 Jun 15;32(12):1276-82.
Benoit M, Koulibaly PM, Migneco O, Darcourt J, Pringuey DJ, Robert PH. Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis. Psychiatry Res. 2002 Jun 15;114(2):103-11.
Hamilton JA, Whitty G, White AR, Jobling MF, Thompson A, Barrow CJ, Cappai R, Beyreuther K, Masters CL. Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF). Brain Res. 2002 Jun 14;940(1-2):49-54.
Obata T. Role of hydroxyl radical formation in neurotoxicity as revealed by in vivo free radical trapping. Toxicol Lett. 2002 Jun 14;132(2):83-93.
Sáez-Valero J, de Ceballos ML, Small DH, de Felipe C. Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid beta-peptide. Neurosci Lett. 2002 Jun 14;325(3):199-202.
Tedgui A, Mallat Z. Platelets in atherosclerosis: a new role for beta-amyloid peptide beyond Alzheimer's disease. Circ Res. 2002 Jun 14;90(11):1145-6.
Mohajeri MH, Saini K, Schultz JG, Wollmer MA, Hock C, Nitsch RM. Passive immunization against beta-amyloid peptide protects CNS neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation. J Biol Chem. 2002 Jun 14; ,
De Meyer GR, De Cleen DM, Cooper S, Knaapen MW, Jans DM, Martinet W, Herman AG, Bult H, Kockx MM. Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis. Circ Res. 2002 Jun 14;90(11):1197-204.
Walzer M, Lorens S, Hejna M, Fareed J, Hanin I, Cornelli U, Lee JM. Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathology. Eur J Pharmacol. 2002 Jun 12;445(3):211-20.
Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, Kaether C, Zheng H, Ghetti B, Haass C, Steiner H. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8025-30.
Kakio A, Nishimoto S, Yanagisawa K, Kozutsumi Y, Matsuzaki K. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry. 2002 Jun 11;41(23):7385-90.
Uchida Y, Gomi F, Masumizu T, Miura Y. Growth inhibitory factor prevents neurite extension and death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging. J Biol Chem. 2002 Jun 10;
Nielsen AL, Holm IE, Johansen M, Bonven BJ, Jorgensen P, Jorgensen AL. A new splice form of glial fibrillary acidic protein, GFAPe, interacts with the presenilin proteins. J Biol Chem. 2002 Jun 10;
Guptha SH, Holroyd E, Campbell G. Progressive lateral ventricular enlargement as a clue to Alzheimer's disease. Lancet. 2002 Jun 8;359(9322):2040.
Andersson K, Olofsson A, Nielsen EH, Svehag SE, Lundgren E. Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem Biophys Res Commun. 2002 Jun 7;294(2):309-14.
Dhandapani KM, Brann DW. Estrogen-Astrocyte interactions: Implications for neuroprotection. BMC Neurosci. 2002 Jun 7;3(1):6.
He L, Chen L, Lou X, Qu A, Zhou Z, Xu T. Evaluation of beta-amyloid peptide 25-35 on calcium homeostasis in cultured rat dorsal root ganglion neurons. Brain Res. 2002 Jun 7;939(1-2):65-75.
Mbebi C, Sée V, Mercken L, Pradier L, Müller U, Loeffler JP. Amyloid precursor protein family-induced neuronal death is mediated by impairment of the neuroprotective calcium/calmodulin protein kinase IV-dependent signaling pathway. J Biol Chem. 2002 Jun 7;277(23):20979-90.
Kim JH, Rah JC, Fraser SP, Chang KA, Djamgoz MB
Roman S, Vivas NM, Badia A, Clos MV. Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain. Neurosci Lett. 2002 Jun 7;325(2):103-106.
Ait-Ghezala G, Abdullah L, Crescentini R, Crawford F, Town T, Singh S, Richards D, Duara R, Mullan M. Confirmation of association between D10S583 and Alzheimer's disease in a case-control sample. Neurosci Lett. 2002 Jun 7;325(2):87-90.
EDELSTEIN-KESHET L, SPIROS A. Exploring the Formation of Alzheimer's Disease Senile Plaques in Silico. J Theor Biol. 2002 Jun 7;216(3):301.
Sadqi M, Hernández F, Pan U, Pérez M, Schaeberle MD, Avila J, Muñoz V. Alpha-helix structure in Alzheimer's disease aggregates of tau-protein. Biochemistry. 2002 Jun 4;41(22):7150-5.
Tabner BJ, Turnbull S, El-Agnaf OM, Allsop D. Formation of hydrogen peroxide and hydroxyl radicals from Abeta and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease(1,2). Free Radic Biol Med. 2002 Jun 1;32(11):1076-83.
De Servi B, La Porta CA, Bontempelli M, Comolli R. Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease. Exp Gerontol. 2002 Jun;37(6):813-21.
Fillenbaum GG, Blazer DG, Burchett BM, Saunders AM, Taylor DH. Apolipoprotein E epsilon4 and risk of mortality in African American and white older community residents. Gerontologist. 2002 Jun;42(3):381-6.
Whitney KD, Watson MA, Collins JL, Benson WG, Stone TM, Numerick MJ, Tippin TK, Wilson JG, Winegar DA, Kliewer SA. Regulation of cholesterol homeostasis by the liver x receptors in the central nervous system. Mol Endocrinol. 2002 Jun;16(6):1378-85.
Arlt S, Beisiegel U, Kontush A. Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease. Curr Opin Lipidol. 2002 Jun;13(3):289-94.
Smits HA, Rijsmus A, van Loon JH, Wat JW, Verhoef J, Boven LA, Nottet HS. Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes. J Neuroimmunol. 2002 Jun;127(1-2):160-8.
Tsuchiya K, Nakayama H, Iritani S, Arai T, Niizato K, Haga C, Matsushita M, Ikeda K. Distribution of basal ganglia lesions in diffuse neurofibrillary tangles with calcification: a clinicopathological study of five autopsy cases. Acta Neuropathol (Berl). 2002 Jun;103(6):555-64.
Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, Comi G, Filippi M. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):742-6.
Ermak G, Harris CD, Davies KJ. The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress. FASEB J. 2002 Jun;16(8):814-24.
Zakzanis KK, Leach L. A shrinking span of temporal continuity in dementia of the Alzheimer's type. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Jun;15(2):143-7.
Sánchez JL, Rodríguez M, Carro J. Influence of Cognitive Reserve on Neuropsychologic Functioning in Alzheimer's Disease Type Sporadic in Subjects of Spanish Nationality. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Jun;15(2):113-122.
Cahn-Weiner DA, Grace J, Ott BR, Fernandez HH, Friedman JH. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Jun;15(2):79-87.
Kaytor MD, Orr HT. The GSK3beta signaling cascade and neurodegenerative disease. Curr Opin Neurobiol. 2002 Jun;12(3):275-8.
Combarros O, Alvarez-Arcaya A, Sánchez-Guerra M, Infante J, Berciano J. Candidate gene association studies in sporadic Alzheimer's disease. Dement Geriatr Cogn Disord. 2002 Jun;14(1):41-54.
Traykov L, Baudic S, Thibaudet MC, Rigaud AS, Smagghe A, Boller F. Neuropsychological deficit in early subcortical vascular dementia: comparison to Alzheimer's disease. Dement Geriatr Cogn Disord. 2002 Jun;14(1):26-32.
Allard P, Englund E, Marcusson J. Caudate nucleus dopamine d(2) receptors in vascular dementia. Dement Geriatr Cogn Disord. 2002 Jun;14(1):22-5.
Nilsson K, Gustafson L, Hultberg B. Relation between Plasma Homocysteine and Alzheimer's Disease. Dement Geriatr Cogn Disord. 2002 Jun;14(1):7-12.
Permanne B, Adessi C, Saborio GP, Fraga S, Frossard MJ, Van Dorpe J, Dewachter I, Banks WA, Van Leuven F, Soto C. Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide. FASEB J. 2002 Jun 1;16(8):860-2.
Borroni B, Colciaghi F, Pastorino L, Archetti S, Corsini P, Cattabeni F, Di Luca M, Padovani A. ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model. Eur Neuropsychopharmacol. 2002 Jun;12(3):195-200.
Chen C, Magee JC, Bazan NG. Cyclooxygenase-2 regulates prostaglandin e(2) signaling in hippocampal long-term synaptic plasticity. J Neurophysiol. 2002 Jun;87(6):2851-7.
Adler KA, Mills PJ, Dimsdale JE, Ziegler MG, Patterson TL, Sloan RP, Grant I. Temporal stability of acute stress-induced changes in leukocyte subsets and cellular adhesion molecules in older adults. Brain Behav Immun. 2002 Jun;16(3):262-74.
Vendeville S, Goossens F, Debreu-Fontaine MA, Landry V, Davioud-Charvet E, Grellier P, Scharpe S, Sergheraert C. Comparison of the Inhibition of Human and Trypanosoma cruzi Prolyl Endopeptidases. Bioorg Med Chem. 2002 Jun;10(6):1719-29.
Dhitavat S, Ortiz D, Shea TB, Rivera ER. Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels. Neurochem Res. 2002 Jun;27(6):501-5.
Kanski J, Aksenova M, Schöneich C, Butterfield DA. Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide (1-42). Free Radic Biol Med. 2002 Jun 1;32(11):1205-11.
Brown CM, Wright E, Colton CA, Sullivan PM, Laskowitz DT, Vitek MP. Apolipoprotein E isoform mediated regulation of nitric oxide release(1,2). Free Radic Biol Med. 2002 Jun 1;32(11):1071-5.
Gibson GE. Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease(1,2). Free Radic Biol Med. 2002 Jun 1;32(11):1061-70.
Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med. 2002 Jun 1;32(11):1050-60.
Stockbridge HL, Lewis D, Eisenberg B, Lee M, Schacher S, Van BELLE G, Keifer M, Brodkin CA, Buchwald D. Brain SPECT: a controlled, blinded assessment of intra-reader and inter-reader agreement. Nucl Med Commun. 2002 Jun;23(6):537-544.
Lleó A, Blesa R, Angelopoulos C, Pastor-Rubio P, Villa M, Oliva R, Bufill E. Transferrin C2 allele, haemochromatosis gene mutations, and risk for Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):820-1. ,
Kril JJ, Patel S, Harding AJ, Halliday GM. Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):747-51.
Solfrizzi V, Panza F, D'Introno A, Colacicco AM, Capurso C, Basile AM, Capurso A. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):732-6. ,
Greicius MD, Geschwind MD, Miller BL. Presenile dementia syndromes: an update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):691-700.
Lemaire L, Fournier J, Ponthus C, Le Fur Y, Confort-Gouny S, Vion-Dury J, Keane P, Cozzone PJ. Magnetic Resonance Imaging of the Neuroprotective Effect of Xaliproden in Rats. Invest Radiol. 2002 Jun;37(6):321-327.
McBride T, Moberg PJ, Arnold SE, Mozley LH, Mahr RN, Gibney M, Kumar A, Gur RE. Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease. Schizophr Res. 2002 Jun 1;55(3):217-27.
Suwata J, Kamata K, Nishijima T, Yoshikawa T, Sano M. New acetylcholinesterase inhibitor (donepezil) treatment for Alzheimer's disease in a chronic dialysis patient. Nephron. 2002 Jun;91(2):330-2.
Ghosh AK, Hong L, Tang J. beta-Secretase as a Therapeutic Target for Inhibitor Drugs. Curr Med Chem. 2002 Jun;9(11):1135-44.
Hooper NM, Turner AJ. The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer s disease. Curr Med Chem. 2002 Jun;9(11):1107-19.
Harding JJ. Viewing molecular mechanisms of ageing through a lens. Ageing Res Rev. 2002 Jun;1(3):465-79.
Petot GJ, Debanne SM, Riedel TM, Smyth KA, Koss E, Lerner AJ, Friedland RP. Use of surrogate respondents in a case control study of dietary risk factors for Alzheimer's disease. J Am Diet Assoc. 2002 Jun;102(6):848-50.
Mendez MF, Ghajarania M, Perryman KM. Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease. Dement Geriatr Cogn Disord. 2002 Jun;14(1):33-40.
Togo T, Sahara N, Yen SH, Cookson N, Ishizawa T, Hutton M, de Silva R, Lees A, Dickson DW. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol. 2002 Jun;61(6):547-56.
Esch T, Stefano GB, Fricchione GL, Benson H. INVITED NEL REVIEW. The role of stress in neurodegenerative diseases and mental disorders. Neuroendocrinol Lett. 2002 Jun;23(3):199-208.
Gasparini L, Netzer WJ, Greengard P, Xu H. Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol Sci. 2002 Jun 1;23(6):288-93.
Solfrizzi V, Panza F, Torres F, Capurso C, D'Introno A, Colacicco AM, Capurso A. Selective attention skills in differentiating between Alzheimer's disease and normal aging. J Geriatr Psychiatry Neurol. 2002 Summer;15(2):99-109.
Myers CE, Kluger A, Golomb J, Ferris S, de Leon MJ, Schnirman G, Gluck MA. Hippocampal atrophy disrupts transfer generalization in nondemented elderly. J Geriatr Psychiatry Neurol. 2002 Summer;15(2):82-90.
Karlawish JH, Casarett D, Propert KJ, James BD, Clark CM. Relationship between Alzheimer's disease severity and patient participation in decisions about their medical care. J Geriatr Psychiatry Neurol. 2002 Summer;15(2):68-72.
Bliwise DL, Rye DB, Dihenia B, Gurecki P. Greater daytime sleepiness in subcortical stroke relative to Parkinson's disease and Alzheimer's disease. J Geriatr Psychiatry Neurol. 2002 Summer;15(2):61-7.
Tractenberg RE, Weiner MF, Patterson MB, Gamst A, Thal LJ. Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes. J Geriatr Psychiatry Neurol. 2002 Summer;15(2):110-7.
Zhu BT. Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab. 2002 Jun;3(3):321-49.
Fiala JC, Spacek J, Harris KM. Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res Brain Res Rev. 2002 Jun 1;39(1):29-54.
Praticò D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol. 2002 Jun 1;59(6):972-6. ,
Kobayashi K, Hayashi M, Nakano H, Fukutani Y, Sasaki K, Shimazaki M, Koshino Y. Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease. Neuropathol Appl Neurobiol. 2002 Jun;28(3):238-251.
Grundman M, Farlow M, Peavy G, Kim HT, Capparelli E, Schultz AN, Salmon DP, Ferris SH, Mobs R, Thomas RG, Schafer K, Campbell K, Hake AM, Schoos B, Thal LJ, Alzheimer's Disease Cooperative Study. A phase I study of AIT-082 in healthy elderly volunteers. J Mol Neurosci. 2002 Jun;18(3):283-93.
Vaucher E, Fluit P, Chishti MA, Westaway D, Mount HT, Kar S. Object recognition memory and cholinergic parameters in mice expressing human presenilin 1 transgenes. Exp Neurol. 2002 Jun;175(2):398-406.
Bamberger ME, Landreth GE. Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist. 2002 Jun;8(3):276-83.
Mukai F, Ishiguro K, Sano Y, Fujita SC. Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta. J Neurochem. 2002 Jun;81(5):1073-83.
Green KN, Peers C. Divergent pathways account for two distinct effects of amyloid beta peptides on exocytosis and Ca(2+) currents: involvement of ROS and NF-kappaB. J Neurochem. 2002 Jun;81(5):1043-51.
Tsai JY, Wolfe MS, Xia W. The Search for gamma-Secretase and Development of Inhibitors. Curr Med Chem. 2002 Jun;9(11):1087-106.
Zec RF, Trivedi MA. Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials. Climacteric. 2002 Jun;5(2):122-34.
McPhaul LW, Wang J, Hol EM, Sonnemans MA, Riley N, Nguyen V, Yuan QX, Lue YH, van Leeuwen FW, French SW. Molecular misreading of the ubiquitin B gene and hepatic mallory body formation. Gastroenterology. 2002 Jun;122(7):1878-85.
Hwang DY, Chae KR, Kang TS, Hwang JH, Lim CH, Kang HK, Goo JS, Lee MR, Lim HJ, Min SH, Cho JY, Hong JT, Song CW, Paik SG, Cho JS, Kim YK. Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB J. 2002 Jun;16(8):805-13.
Ohrui T, Arai H, Ichinose M, Matsui T, Yamaya M, Sasaki H. Relationship between asthma severity and progression of Alzheimer's disease. Thorax. 2002 Jun;57(6):561.
Smith MA, Perry G, Pryor WA. Causes and consequences of oxidative stress in Alzheimer's disease(1,2). Free Radic Biol Med. 2002 Jun 1;32(11):1049.
Dimakopoulos AC, Mayer RJ. Aspects of neurodegeneration in the canine brain. J Nutr. 2002 Jun;132(6):1579S-82S.
Goodwin JS. Language and medicine: thinking and talking about Alzheimer's disease. Gerontologist. 2002 Jun;42(3):293-6.
Lanzino G, Lanzino DJ, Wang D. Cerebrovascular disease and cognitive dysfunction. Neurol Res. 2002 Jun;24(4):331-6.
Staddon S, Arranz MJ, Mancama D, Mata I, Kerwin RW. Clinical applications of pharmacogenetics in psychiatry. Psychopharmacology (Berl). 2002 Jun;162(1):18-23.
Henkel K, Zerr I, Hertel A, Gratz KF, Schröter A, Tschampa HJ, Bihl H, Büll U, Grünwald F, Drzezga A, Spitz J, Poser S. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol. 2002 Jun;249(6):699-705.
Poduslo SE, Shook B, Drigalenko E, Yin X. Lack of association of the two polymorphisms in alpha-2 macroglobulin with Alzheimer disease. Am J Med Genet. 2002 Jun 1;110(1):30-5. , ,
Rösler M. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. Int J Clin Pract Suppl. 2002 Jun;(127):20-36.
Jefferson AL, Cosentino SA, Ball SK, Bogdanoff B, Leopold N, Kaplan E, Libon DJ. Errors produced on the mini-mental state examination and neuropsychological test performance in Alzheimer's disease, ischemic vascular dementia, and Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2002 Summer;14(3):311-20.
Tractenberg RE, Gamst A, Thomas RG, Patterson M, Schneider LS, Thal LJ. Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2002 Summer;14(3):303-10.
Poirier J. Evidence that the clinical effects of cholinesterase inhibitors are related to potency and targeting of action. Int J Clin Pract Suppl. 2002 Jun;(127):6-19.
Yanagisawa K. [Alzheimer's disease and cholesterol] Seikagaku. 2002 Jun;74(6):455-60.
Defelice FG, Ferreira ST. Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease. An Acad Bras Cienc. 2002 Jun;74(2):265-284.
Bhagat YA, Obenaus A, Richardson JS, Kendall EJ. Evolution of beta-amyloid induced neuropathology: magnetic resonance imaging and anatomical comparisons in the rodent hippocampus. MAGMA. 2002 Jun;14(3):223-32.
Bassiony MM, Warren A, Rosenblatt A, Baker A, Steinberg M, Steele CD, Sheppard JM, Lyketsos CG. The relationship between delusions and depression in Alzheimer's disease. Int J Geriatr Psychiatry. 2002 Jun;17(6):549-56.
Lanctôt KL, Herrmann N, van Reekum R, Eryavec G, Naranjo CA. Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease. Int J Geriatr Psychiatry. 2002 Jun;17(6):531-41.
Hedley R, Hallmayer J, Groth DM, Brooks WS, Gandy SE, Martins RN. Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Ann Neurol. 2002 Jun;51(6):795-7. ,
Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann Neurol. 2002 Jun 1;51(6):783-6.
Wolfson C, Oremus M, Shukla V, Momoli F, Demers L, Perrault A, Moride Y. Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness. Clin Ther. 2002 Jun;24(6):862-86; discussion 837.
Emre M. Switching cholinesterase inhibitors in patients with Alzheimer's disease. Int J Clin Pract Suppl. 2002 Jun;(127):64-72.
Karlsson T, Börjesson A, Adolfsson R, Nilsson LG. Successive memory test performance and priming in Alzheimer's disease: evidence from the word-fragment completion task. Cortex. 2002 Jun;38(3):341-55.
Compton J, van Amelsvoort T, Murphy D. Mood, cognition and Alzheimer's disease. Best Pract Res Clin Obstet Gynaecol. 2002 Jun;16(3):357-70.
Winkler DT, Biedermann L, Tolnay M, Allegrini PR, Staufenbiel M, Wiessner C, Jucker M. Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy. Ann Neurol. 2002 Jun 1;51(6):790-3.
Wen PH, Shao X, Shao Z, Hof PR, Wisniewski T, Kelley K, Friedrich VL, Ho L, Pasinetti GM, Shioi J, Robakis NK, Elder GA. Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice. Neurobiol Dis. 2002 Jun 1;10(1):8-19. ,
Higgins GA, Enderlin M, Fimbel R, Haman M, Grottick AJ, Soriano M, Richards JG, Kemp JA, Gill R. Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia. Eur J Neurosci. 2002 Jun;15(11):1827-40.
Hardin S, Schooley B. A story of Pick's disease: a rare form of dementia. J Neurosci Nurs. 2002 Jun;34(3):117-22.
Verpillat P, Camuzat A, Hannequin D, Thomas-Anterion C, Puel M, Belliard S, Dubois B, Didic M, Michel BF, Lacomblez L, Moreaud O, Sellal F, Golfier V, Campion D, Clerget-Darpoux F, Brice A. Association Between the Extended tau Haplotype and Frontotemporal Dementia. Arch Neurol. 2002 Jun;59(6):935-9.
Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL. Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol. 2002 Jun;28(3):218-27.
Hase M, Yagi Y, Taru H, Tomita S, Sumioka A, Hori K, Miyamoto K, Sasamura T, Nakamura M, Matsuno K, Suzuki T. Expression and characterization of the Drosophila X11-like/Mint protein during neural development. J Neurochem. 2002 Jun;81(6):1223-32.
Ishunina TA, Swaab DF. Neurohypophyseal peptides in aging and Alzheimer's disease. Ageing Res Rev. 2002 Jun;1(3):537-58.
Tsuchiya K, Ikeda K, Niizato K, Watabiki S, Anno M, Taki K, Haga C, Iritani S, Matsushita M. Parkinson's disease mimicking senile dementia of the Alzheimer type: a clinicopathological study of four autopsy cases. Neuropathology. 2002 Jun;22(2):77-84.
Lee TH. By the way, doctor. I read in the paper that cholesterol might be good for the brain and prevent Alzheimer's disease. So I'm wondering if taking a statin is really such a good idea. Harv Health Lett. 2002 Jun;27(8):8.
Avila J, Lim F, Moreno F, Belmonte C, Cuello AC. Tau function and dysfunction in neurons: its role in neurodegenerative disorders. Mol Neurobiol. 2002 Jun;25(3):213-31.
Bradley KM, Bydder GM, Budge MM, Hajnal JV, White SJ, Ripley BD, Smith AD. Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. Br J Radiol. 2002 Jun;75(894):506-513. ,
Wang Q, Wang J. Injection of bradykinin or cyclosporine A to hippocampus induces Alzheimer-like phosphorylation of Tau and abnormal behavior in rats. Chin Med J (Engl). 2002 Jun;115(6):884-7.
Marchetti RL, Bottino CM, Azevedo D, Marie SK, Castro CC. [Reliability of mesial temporal lobe volumetric measures] Arq Neuropsiquiatr. 2002 Jun;60(2-B):420-8.
Colombo JA, Quinn B, Puissant V. Disruption of astroglial interlaminar processes in Alzheimer's disease. Brain Res Bull. 2002 Jun;58(2):235-42.
Dave KR, Syal AR, Katyare SS. Effect of long-term aluminum feeding on kinetics attributes of tissue cholinesterases. Brain Res Bull. 2002 Jun;58(2):225-33.
Arroyo G, Aldea M, Fuentealba J, Garc a AG. [Nicotinic Receptor, galantamine and Alzheimer disease] Rev Neurol. 2002 Jun 1;34(11):1057-65.
Shigenobu K, Ikeda M, Fukuhara R, Maki N, Hokoishi K, Nebu A, Yasuoka T, Komori K, Tanabe H. The Stereotypy Rating Inventory for frontotemporal lobar degeneration. Psychiatry Res. 2002 Jun 1;110(2):175-87.
Cottington EM, LaMantia C, Stabler SP, Allen RH, Tangerman A, Wagner C, Zeisel SH, Mudd SH. Adverse event associated with methionine loading test: a case report. Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):1046-50.
Smith JD. Apolipoproteins and aging: emerging mechanisms. Ageing Res Rev. 2002 Jun;1(3):345-65.
Mattson MP, Mattson EP. Amyloid peptide enhances nail rusting: novel insight into mechanisms of aging and Alzheimer's disease. Ageing Res Rev. 2002 Jun;1(3):327-30.
Chantal S, Labelle M, Bouchard RW, Braun CM, Boulanger Y. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. Arch Neurol. 2002 Jun;59(6):955-62.
Leutz S, Steiner B, Marques CA, Haass C, Müller WE, Eckert A. Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer's APP mutation and sensitizes cells to staurosporine-induced cell death. J Mol Neurosci. 2002 Jun 1;18(3):189-201.
Cummings JL, Frank JC, Cherry D, Kohatsu ND, Kemp B, Hewett L, Mittman B. Guidelines for managing Alzheimer's disease: part I. Assessment. Am Fam Physician. 2002 Jun 1;65(11):2263-72.
Mok SS, Turner BJ, Beyreuther K, Masters CL, Barrow CJ, Small DH. Toxicity of substrate-bound amyloid peptides on vascular smooth muscle cells is enhanced by homocysteine. Eur J Biochem. 2002 Jun;269(12):3014-3022.
Augustinack JC, Sanders JL, Tsai LH, Hyman BT. Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles. J Neuropathol Exp Neurol. 2002 Jun;61(6):557-64.
Maiorini AF, Gaunt MJ, Jacobsen TM, McKay AE, Waldman LD, Raffa RB. Potential novel targets for Alzheimer pharmacotherapy: I. Secretases. J Clin Pharm Ther. 2002 Jun;27(3):169-83.
Cejudo JC, Boada M, Tàrraga L, López OL, Kaufer D. [Neuropsychiatric inventory questionnaire (NPI-Q): Spanish validation of an abridged form of the Neuropsychiatric Inventory (NPI)] Neurologia. 2002 Jun;17(6):317-23.
Copin B, Brézin AP, Valtot F, Dascotte JC, Béchetoille A, Garchon HJ. Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet. 2002 Jun;70(6):1575-81.
Dermaut B, Theuns J, Sleegers K, Hasegawa H, van den Broeck M, Vennekens K, Corsmit E, St George-Hyslop P, Cruts M, van Duijn CM, van Broeckhoven C. The Gene Encoding Nicastrin, a Major gamma-Secretase Component, Modifies Risk for Familial Early-Onset Alzheimer Disease in a Dutch Population-Based Sample. Am J Hum Genet. 2002 Jun;70(6):1568-74. ,
Yoshida T. [SNP project in the Millennium Genome Project, Japan] Gan To Kagaku Ryoho. 2002 Jun;29(6):963-7.
Fruton JS. A history of pepsin and related enzymes. Q Rev Biol. 2002 Jun;77(2):127-47.
Kuusisto E, Salminen A, Alafuzoff I. Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation. Neuropathol Appl Neurobiol. 2002 Jun;28(3):228-37.
Cheng G, Yu Z, Zhou D, Mattson MP. Phosphatidylinositol-3-Kinase-Akt Kinase and p42/p44 Mitogen-Activated Protein Kinases Mediate Neurotrophic and Excitoprotective Actions of a Secreted Form of Amyloid Precursor Protein. Exp Neurol. 2002 Jun;175(2):407-14.
Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem. 2002 Jun;81(5):1084-91.
Herrup K, Arendt T. Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease. J Alzheimers Dis. 2002 Jun;4(3):243-7.
Butterfield DA, Griffin S, Munch G, Pasinetti GM. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J Alzheimers Dis. 2002 Jun;4(3):193-201.
Crutcher KA, Robinson SR, Smith MA. Challenging Views of Alzheimer's disease. J Alzheimers Dis. 2002 Jun;4(3):129-30.
Lilienfeld S. Galantamine - a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. CNS Drug Rev. 2002 Summer;8(2):159-76.
Guereño MT, Diez R. [Cytokines and psychiatry] Vertex. 2002 Jun;13(48):111-9.
Hauw JJ, Duyckaerts C. Dementia, the fate of brain? Neuropathological point of view. C R Biol. 2002 Jun;325(6):655-64.
Siegler IC, Bastian LA, Steffens DC, Bosworth HB, Costa PT. Behavioral medicine and aging. J Consult Clin Psychol. 2002 Jun;70(3):843-51.
Lahiri DK, Utsuki T, Chen D, Farlow MR, Shoaib M, Ingram DK, Greig NH. Nicotine Reduces the Secretion of Alzheimer's beta-Amyloid Precursor Protein Containing beta-Amyloid Peptide in the Rat without Altering Synaptic Proteins. Ann N Y Acad Sci. 2002 Jun;965:364-72.
Lahiri DK, Nall C, Chen D, Zaphiriou M, Morgan C, Nurnberger JI. Developmental Expression of the beta-Amyloid Precursor Protein and Heat-Shock Protein 70 in the Cerebral Hemisphere Region of the Rat Brain. Ann N Y Acad Sci. 2002 Jun;965:324-33.
Virmani A, Gaetani F, Imam S, Binienda Z, Ali S. The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Ann N Y Acad Sci. 2002 Jun;965:225-32.
Suzuki M, Desmond TJ, Albin RL, Frey KA. Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias. Ann Neurol. 2002 Jun;51(6):767-71.
Ferroni S, Marchini C, Ogata T, Schubert P. Recovery of deficient cholinergic calcium signaling by adenosine in cultured rat cortical astrocytes. J Neurosci Res. 2002 Jun 1;68(5):615-21.
J M Hoozemans J, Veerhuis R, J M Rozemuller A, Eikelenboom P. The pathological cascade of Alzheimer's disease: the role of inflammation and its therapeutic implications. Drugs Today (Barc). 2002 Jun;38(6):429-43.
Mackic JB, Bading J, Ghiso J, Walker L, Wisniewski T, Frangione B, Zlokovic BV. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vascul Pharmacol. 2002 Jun 1;38(6):303-13.
Naarding P, Leentjens AF, van Kooten F, Verhey FR. Disease-specific properties of the hamilton rating scale for depression in patients with stroke, Alzheimer's dementia, and Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2002 Summer;14(3):329-34.
Sultzer DL, Chen ST, Brown CV, Mahler ME, Cummings JL, Hinkin CH, Mandelkern MA. Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings. J Neuropsychiatry Clin Neurosci. 2002 Summer;14(3):262-9.
Lapidus AM. [Hormonal replacement therapy. Benefits and risks] Vertex. 2002 Jun-Aug;13(48):120-8.
Kikuchi S, Shinpo K, Ogata A, Tsuji S, Takeuchi M, Makita Z, Tashiro K. Detection of Nepsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002 Jun;3(2):63-8.
Mori C, Spooner ET, Wisniewsk KE, Wisniewski TM, Yamaguch H, Saido TC, Tolan DR, Selkoe DJ, Lemere CA. Intraneuronal Abeta42 accumulation in Down syndrome brain. Amyloid. 2002 Jun;9(2):88-102.
Kumari V, Mitterschiffthaler MT, Sharma T. Neuroimaging to predict preclinical Alzheimer's disease. Hosp Med. 2002 Jun;63(6):341-5.
Pandav R, Mehta A, Belle SH, Martin DE, Chandra V, Dodge HH, Ganguli M. Data management and quality assurance for an International project: the Indo-US Cross-National Dementia Epidemiology Study. Int J Geriatr Psychiatry. 2002 Jun;17(6):510-8.
Ala TA, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ. The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2002 Jun;17(6):503-9.
Imbimbo BP. Toxicity of beta-amyloid vaccination in patients with Alzheimer's disease. Ann Neurol. 2002 Jun;51(6):794.
Berchtold NC, Kesslak JP, Cotman CW. Hippocampal brain-derived neurotrophic factor gene regulation by exercise and the medial septum. J Neurosci Res. 2002 Jun 1;68(5):511-21.
Savolainen S, Hurskainen H, Paljärvi L, Alafuzoff I, Vapalahti M. Five-year outcome of normal pressure hydrocephalus with or without a shunt: predictive value of the clinical signs, neuropsychological evaluation and infusion test. Acta Neurochir (Wien). 2002 Jun;144(6):515-23.
Kuslansky G, Buschke H, Katz M, Sliwinski M, Lipton RB. Screening for Alzheimer's disease: the memory impairment screen versus the conventional three-word memory test. J Am Geriatr Soc. 2002 Jun;50(6):1086-91.
Palotás A, Kálmán J, Palotás M, Juhász A, Janka Z, Penke B. beta-Amyloid-induced increase in the resting intracellular calcium concentration gives support to tell Alzheimer lymphocytes from control ones. Brain Res Bull. 2002 Jun;58(2):203-5.
Luttmann E, Linnemann E, Fels G. Galanthamine as bis-functional ligand for the acetylcholinesterase. J Mol Model (Online). 2002 Jun;8(6):208-16.
Farlow MR. Do cholinesterase inhibitors slow progression of Alzheimer's disease? Int J Clin Pract Suppl. 2002 Jun;(127):37-44.
Pepersack T. [In Process Citation] Rev Med Brux. 2002 Jun;23(3):150-5.
Bading JR, Yamada S, Mackic JB, Kirkman L, Miller C, Calero M, Ghiso J, Frangione B, Zlokovic BV. Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy. J Drug Target. 2002 Jun;10(4):359-68.
Hayashi A, Suzuki K, Ohigashi Y, Takatsuki Y, Nakano Y, Yamadori A, Mori E. [Writing Kanji without semantics in a case with probable Alzheimer's disease] No To Shinkei. 2002 Jun;54(6):481-8.
De Servi B, La Porta C, Bontempelli M, Comolli R. Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease. Exp Gerontol. 2002 Jun;37(6):813. ,
Alvarez G, Muñoz-Montaño JR, Satrústegui J, Avila J, Bogónez E, Díaz-Nido J. Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease. Bipolar Disord. 2002 Jun;4(3):153-65.
Amieva H, Lafont S, Auriacombe S, Le Carret N, Dartigues J, Orgogozo J, Colette F. Inhibitory breakdown and dementia of the Alzheimer type: a general phenomenon? J Clin Exp Neuropsychol. 2002 Jun;24(4):503-16.
Bowser R, Smith MA. Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. J Alzheimers Dis. 2002 Jun 1;4(3):249-54.
Iqbal K, Grundke-Iqbal I. Neurofibrillary pathology leads to synaptic loss and not the other way around in Alzheimer disease. J Alzheimers Dis. 2002 Jun;4(3):235-8.
Grant WB, Campbell A, Itzhaki RF, Savory J. The significance of environmental factors in the etiology of Alzheimer's disease. J Alzheimers Dis. 2002 Jun 1;4(3):179-89.
Gaddi A, Cicero AF, Poli A, Nascetti S, Inzitari D, Italian Group for the Study of Dysmetabolic Diseases and Atherosclerosis. Cerebrovascular disease in Italy and Europe: it is necessary to prevent a 'pandemia'. J Cardiovasc Risk. 2002 Jun;9(3):143-5.
Srinivasan V. Melatonin oxidative stress and neurodegenerative diseases. Indian J Exp Biol. 2002 Jun;40(6):668-79.
Yamashita M, Yamamoto T, Yamada M, Okino S, Fujita T. [Sporadic cerebral amyloid angiopathy presenting with dementia and prominent capillary beta-amyloid deposition: a case report] Rinsho Shinkeigaku. 2002 Jun;42(6):530-5.
Obara Y, Nakahata N. The Signaling Pathway of Neurotrophic Factor Biosynthesis. Drug News Perspect. 2002 Jun;15(5):290-298.
Rapoport SI. Hydrogen magnetic resonance spectroscopy in Alzheimer's disease. Lancet Neurol. 2002 Jun;1(2):82.
McCrone J. An evolutionary root for Alzheimer's disease? Lancet Neurol. 2002 Jun 1;1(2):79.
Jacobson A. Zinc transport in Alzheimer's pathology. Lancet Neurol. 2002 Jun 1;1(2):76.
Senior K. Passive immunisation reverses memory loss in Alzheimer's mice. Lancet Neurol. 2002 Jun 1;1(2):76.
Tarkowski E. Cytokines in dementias. Curr Drug Targets Inflamm Allergy. 2002 Jun;1(2):193-200.
Kensinger EA, Brierley B, Medford N, Growdon JH, Corkin S. Effects of normal aging and Alzheimer's disease on emotional memory. Emotion. 2002 Jun;2(2):118-34.
Kong QL, Zhang JM, Zhang ZX, Ge PJ, Xu YJ, Mi RS, Zhao YH, Sui YP, He W. [Serum levels of macrophage colony stimulating factor in the patients with Alzheimer's disease] Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002 Jun 1;24(3):298-301.
Morgan D, Keller RK. What evidence would prove the amyloid hypothesis? Towards rational drug treatments for Alzheimer's disease. J Alzheimers Dis. 2002 Jun;4(3):257-60.
Blass JP, Gibson GE, Hoyer S. The role of the metabolic lesion in Alzheimer's disease. J Alzheimers Dis. 2002 Jun;4(3):225-32.
Grammas P, Yamada M, Zlokovic B. The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer's disease. J Alzheimers Dis. 2002 Jun 1;4(3):217-23.
Ashford JW, Mortimer JA. Non-familial Alzheimer's disease is mainly due to genetic factors. J Alzheimers Dis. 2002 Jun;4(3):169-77.
Rebeck GW, Kindy M, LaDu MJ. Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. J Alzheimers Dis. 2002 Jun;4(3):145-54.
No comments:
Post a Comment